Author:
Budhathoki Nibash,Timilsina Sunita,Ram Bebu,Marks Douglas
Abstract
Prevalence of haemoglobin sickle-β+ thalassaemia (Hb S/β+thal) is variable with geography ranging from 0.2% to 10% among sickle cell patients. Clinical presentation of Hb S/β+thal patients depends on HbA level, with milder disease often going undiagnosed. However, rarely these patients can present with a fulminant vaso-occlusive crisis (VOC). Given VOC can present with non-specific symptoms, the diagnosis and treatment is often delayed. Here, we present a patient who initially developed altered mental status, pancytopenia and multiorgan failure due a critical VOC resulting in bone marrow necrosis and fat embolism. Subsequent workup confirmed that our patient had Sickle-β+ thalassaemia, which had gone undiagnosed, despite subclinical evidence of haemolysis on routine lab work for years. Following diagnosis and initiation of RBC exchange, he improved significantly and was discharged home. High index of suspicion and bone marrow biopsy is vital for early diagnosis and management of this rare condition.
Reference21 articles.
1. Sickle-cell disease
2. Pathogenesis and Treatment of Sickle Cell Disease
3. The hereditary haemolytic anaemias;Dacie;J R Coll Physicians Lond,1974
4. Differences in the clinical and genotypic presentation of sickle cell disease around the world;Saraf;Paediatr Respir Rev,2014
5. The compound state: Hb S/beta-thalassemia;Figueiredo;Rev Bras Hematol Hemoter,2015
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献